Home › Blog › Weight Loss › Weight Loss Injections Bristol
Weight Loss Injections Bristol 2026: BNSSG ICB Routes, Ethnic BMI Adjustments, and Private From £139
Get Weight Loss Injections in Bristol — Delivered Tomorrow, No Waiting List
Same MHRA-licensed Mounjaro and Wegovy as BNSSG ICB · GPhC No. 1033729 · NHS-contracted · SCOPE Obesity Accredited · LegitScript Certified · Free monthly check-ins
Wegovy from £99.99/month
✓ Free monthly check-ins
✓ Free starter pack
✓ No subscription
✓ Next-day to all BS postcodes
Bristol is one of England’s most vibrant and culturally diverse cities, and is served by NHS Bristol, North Somerset and South Gloucestershire ICB — known as BNSSG ICB — covering a combined population of approximately 1 million people. Bristol City’s overall adult obesity rate of approximately 27% is below the national average of 29%, but this headline figure conceals stark and well-documented inequality: Clifton and Redland have obesity rates below 15%, while Hartcliffe, Withywood, Lawrence Hill, and Filwood exceed 38–40%.
There are two important and often-overlooked facts about Bristol’s weight loss injection landscape in 2026. First: BNSSG ICB has among the shorter NHS tier 3 waiting times in England at 12–18 months — still a significant delay, but notably shorter than the 18–36 months common in Liverpool, Birmingham, and parts of London. Second: Bristol has one of the UK’s largest Somali communities — concentrated in Lawrence Hill, Easton, and Eastville — alongside significant South Asian and Black African/Caribbean populations. For these communities, the ethnic BMI adjustments at Slinic are clinically critical and represent eligibility that many patients don’t know exists.
How to Get Weight Loss Injections in Bristol: NHS vs Private
| Factor | NHS — BNSSG ICB | Private — Slinic |
|---|---|---|
| Eligibility threshold | BMI 35+ with qualifying conditions (tier 3) · BMI 27+ with CVD no T2D (April 2026 Wegovy) · T2D patients (QOF Mounjaro) | BMI 30+ (no condition) · BMI 27+ with 1 qualifying condition · Ethnic group adjustments apply |
| GP referral needed | Yes — tier 3 referral or April 2026 GP direct pathways | No — free online assessment directly with Slinic |
| Waiting time | 12–18 months from GP referral | 24–48 hours from assessment to delivery |
| Cost in England | £9.90 per item (NHS prescription charge) · Free with T2D exemption, age 60+, or qualifying benefits | £139–£285/month (Mounjaro) · £99.99–£209.99 (Wegovy) · £4.99 delivery |
| Clinical monitoring | BNSSG ICB tier 3 multidisciplinary team | Free monthly check-ins with Slinic superintendent pharmacist — always included in price |
| Free starter pack | Via BNSSG ICB tier 3 service | ✓ Needles + sharps bin with first order |
| Can run simultaneously? | ✓ Yes — being on the BNSSG waiting list and starting Slinic privately are fully compatible. Starting private does not affect your NHS position. Bristol has shorter waits than most — but 12–18 months is still 12–18 months without treatment. | |
Bristol and BNSSG ICB: Area-by-Area Breakdown
BNSSG ICB is unusual in covering three distinct local authority areas: Bristol City Council, North Somerset Council, and South Gloucestershire Council. NHS tier 3 weight management services are commissioned centrally but delivered across this geography. Understanding which area you live in, and its specific obesity and deprivation profile, contextualises both your NHS and private options.
| Area | Adult obesity rate | Key characteristics | BS postcodes |
|---|---|---|---|
| Lawrence Hill, Barton Hill, St George | 34–40% | Bristol’s most deprived ward. Large South Asian (Bangladeshi, Pakistani), Black African/Caribbean, and Somali communities. Very high T2D and CVD rates. Ethnic BMI adjustments widely applicable. Highest NHS tier 3 demand in Bristol. | BS5, BS2 |
| Hartcliffe, Withywood, Filwood | 36–40% | Predominantly white British deprived community in South Bristol. Highest obesity rates in Bristol City. High CVD and T2D burden — April 2026 Wegovy CVD pathway relevant for eligible patients. | BS13, BS14 |
| Southmead, Horfield, Lockleaze | 32–36% | North Bristol. Above-average deprivation and obesity. Southmead Hospital is the main North Bristol acute trust. High NHS demand for weight management services. | BS7, BS10 |
| Easton, Eastville, Redfield | 28–34% | Highly diverse — significant Somali, South Asian, and Black African/Caribbean communities. One of Bristol’s most culturally varied areas. Ethnic BMI adjustments relevant for a large proportion of the population here. | BS5, BS16 |
| Bedminster, Knowle, Brislington | 26–32% | South Bristol. Mixed demographics. Average to above-average obesity rates. Some deprivation in parts of Bedminster and Knowle West. | BS3, BS4, BS14 |
| Henleaze, Redland, Bishopston | 18–24% | More affluent North Bristol. Below-average obesity. Higher proportion of patients choosing Slinic private prescribing for speed and clinical credentials rather than waiting 12–18 months. | BS6, BS7, BS9 |
| Clifton, Cotham, Hotwells | 12–18% | Most affluent Bristol areas. Significantly below-average obesity. Very high Slinic private prescribing uptake. | BS8 |
| North Somerset (Weston-super-Mare, Portishead, Clevedon) | 28–33% | Older demographic overall — Weston-super-Mare in particular. Above-average CVD rates in older population. April 2026 cardiovascular Wegovy pathway particularly relevant for eligible patients here. Rural areas benefit from Slinic’s online model. | BS20–BS24, TA22–TA24 |
| South Gloucestershire (Kingswood, Yate, Thornbury, Filton) | 24–29% | More affluent suburban areas overall. Filton has significant diversity linked to aerospace industry workforce. Yate and Thornbury more rural — Slinic online model removes access barriers. Higher private prescribing uptake. | BS15, BS30, BS32, BS34, BS35, BS36, BS37 |
| Nailsea, Backwell, Long Ashton | 22–27% | Affluent rural/suburban North Somerset. Below-average obesity. Slinic next-day delivery to all BS48 and surrounding postcodes. | BS48, BS41 |
The Somali and South Asian Community — The Most Important Eligibility Factor Many Bristol Patients Don’t Know About
Bristol has one of the largest Somali communities in the United Kingdom — estimated at 20,000–30,000 people, concentrated primarily in Lawrence Hill, Easton, Eastville, and parts of Barton Hill and St George. Bristol’s Somali community is the most clinically significant group in the city for weight loss injection eligibility, and the one where the ethnic BMI adjustments matter most.
The clinical evidence for this is well-established in peer-reviewed literature. Research into Somali community health — including studies published in the Diabetes UK position statement on diabetes risk in the Somali community — consistently shows elevated rates of type 2 diabetes and cardiovascular disease risk factors at lower BMIs than the white European reference population. The combination of diet, genetic factors, and metabolic differences means that a Somali patient with BMI 24 may face equivalent or greater T2D and cardiovascular risk as a white European patient with BMI 30.
For Bristol’s South Asian community — concentrated in Lawrence Hill (Bangladeshi and Pakistani communities), Easton, and parts of Fishponds — the same BMI adjustment principles apply. The British Heart Foundation’s South Asian heart health guidance documents the significantly elevated cardiovascular risk at lower BMIs in South Asian populations.
| Ethnic background | Standard Slinic threshold | Adjusted Slinic threshold | Bristol communities most affected |
|---|---|---|---|
| Somali | BMI 30+ (no condition) · BMI 27+ (with condition) | BMI 27.5+ (no condition) · BMI 23+ (with condition) | Lawrence Hill, Easton, Eastville, Barton Hill, St George |
| South Asian (Pakistani, Bangladeshi, Indian, Sri Lankan) | BMI 30+ · BMI 27+ | BMI 27.5+ · BMI 23+ | Lawrence Hill, Easton, parts of Fishponds and Knowle |
| Black African / Black Caribbean | BMI 30+ · BMI 27+ | BMI 27.5+ · BMI 23+ | Easton, Eastville, Lawrence Hill, Southmead, Barton Hill |
| Chinese / East Asian | BMI 30+ · BMI 27+ | BMI 27.5+ · BMI 23+ | City centre, University of Bristol areas, Clifton |
NHS Weight Loss Injections in Bristol: The Three Routes in 2026
BNSSG ICB Tier 3 Weight Management
⏰ Wait: 12–18 months — shorter than most English ICBs
The primary NHS route for Bristol patients. Your GP refers you to BNSSG ICB’s tier 3 specialist weight management service. Eligibility: BMI 35 or above with at least one qualifying condition under NICE TA1026. Tier 3 services in Bristol are delivered through University Hospitals Bristol and Weston NHS Foundation Trust and commissioned services. NHS prescription charge: £9.90 per item in England (free with T2D exemption certificate, age 60+, or qualifying benefits).
- BMI 35+ with at least one qualifying condition
- GP referral required — ask your GP TODAY
- 12–18 months typical wait from referral — shorter than most English ICBs
- Medication: Mounjaro or Wegovy depending on clinical recommendation
- NHS prescription charge: £9.90 per item — free with exemption certificate
GP Cardiovascular Pathway — Wegovy for CVD Patients
⚡ Potentially weeks at GP level — bypasses tier 3
Following NICE’s April 2026 cardiovascular guidance based on the SELECT trial (NEJM 2023) — 20% MACE reduction, Bristol GPs can now prescribe Wegovy directly for patients with:
- BMI 27 or above
- Established cardiovascular disease: prior myocardial infarction, prior stroke or TIA, or peripheral arterial disease
- No type 2 diabetes
This pathway is particularly relevant for North Somerset patients — Weston-super-Mare and the surrounding area has an older, higher-CVD demographic where this pathway could be clinically transformative. Some Bristol GP practices are already prescribing through this route. If you have had a heart attack, stroke, or TIA and your BMI is 27+: ask your Bristol GP about the NICE April 2026 cardiovascular semaglutide prescribing pathway today.
QOF Type 2 Diabetes Pathway — Mounjaro for T2D Patients
⚡ Potentially weeks — ask your Bristol GP
From April 2026, Mounjaro is incorporated into the NHS GP QOF for type 2 diabetes. BNSSG ICB GP practices participating can prescribe Mounjaro for eligible T2D patients without tier 3 referral. This is particularly significant for Bristol’s Lawrence Hill, Easton, and Eastville communities where South Asian, Somali, and Black African/Caribbean patients have above-average T2D prevalence.
- Type 2 diabetes — the qualifying criterion
- GP practice must have adopted the QOF T2D pathway — rollout ongoing across BNSSG ICB
- Mounjaro only — the T2D licence does not extend to Wegovy
- Potentially weeks rather than 12–18 months for eligible patients
If you have type 2 diabetes: ask your Bristol GP whether your practice has adopted the QOF tirzepatide T2D prescribing pathway.
Step 1 (Today): Ask your Bristol GP for a BNSSG ICB tier 3 referral. Also ask about the April 2026 cardiovascular Wegovy pathway (BMI 27+ with CVD, no T2D) and the QOF T2D Mounjaro pathway (T2D patients). Start the NHS clock now.
Step 2 (Today): Complete Slinic’s free 2-minute eligibility assessment. If eligible, medication is at your Bristol address tomorrow.
Step 3: Continue private Slinic treatment while waiting. Begin losing weight now — not in 12–18 months.
Step 4 (When BNSSG appointment arrives): Transition to NHS supply. £9.90/item in England (or free with exemption). No restart from the lowest dose. Your Slinic clinical records give the NHS team a complete treatment history.
Starting private treatment does not affect your BNSSG NHS waiting list position.
Can’t Wait 12–18 Months for BNSSG? No Waiting List at Slinic
Mounjaro from £139 · Wegovy from £99.99 · Next-day to all BS postcodes · Free monthly check-ins · GPhC No. 1033729 · NHS-contracted
Mounjaro for Bristol T2D Patients — The Case for Starting Now
Bristol’s T2D prevalence is approximately 7.2% of adults — above the national average — driven by deprivation and the ethnically diverse communities in Lawrence Hill, Easton, and Eastville. For Bristol T2D patients, Mounjaro offers a combination no other weight loss medication can match in 2026:
ul>
Private Weight Loss Injections Bristol — Slinic’s Fixed 2026 Prices
MHRA-licensed Mounjaro from Eli Lilly’s authorised UK supply chain and Wegovy from Novo Nordisk’s authorised UK supply chain. Fixed 2026 prices. No subscription. Next-day delivery to all Bristol and BNSSG area postcodes.
| Dose | Slinic price | Delivery | Monthly total | Treatment stage & clinical data |
|---|---|---|---|---|
| Mounjaro 2.5mg | £139.00 | £4.99 | £143.99 | Starting dose (weeks 1–4). Body adaptation. Appetite quietens noticeably within 1–2 weeks. Free starter pack (needles + sharps bin) with first order. |
| Mounjaro 5mg | £165.00 | £4.99 | £169.99 | First therapeutic dose (weeks 5–8). Weight loss accelerating. |
| Mounjaro 7.5mg | £225.00 | £4.99 | £229.99 | Mid-escalation. ~8–9% average cumulative weight loss in trial data. |
| Mounjaro 10mg | £255.00 | £4.99 | £259.99 | Upper escalation. 19.5% average weight loss at this dose in SURMOUNT-1. |
| Mounjaro 12.5mg | £275.00 | £4.99 | £279.99 | High maintenance. Near-maximum efficacy. |
| Mounjaro 15mg | £285.00 | £4.99 | £289.99 | Maximum dose. 22.5% average weight loss at 72 weeks (SURMOUNT-1 · NEJM 2022). 57% of patients achieved 20%+. |
| Wegovy 0.25mg | £99.99 | £4.99 | £104.98 | Starting dose. Free starter pack included. |
| Wegovy 0.5mg | £109.99 | £4.99 | £114.98 | Month 2. |
| Wegovy 1mg | £114.99 | £4.99 | £119.98 | Month 3. Entering therapeutic range. |
| Wegovy 1.7mg | £159.99 | £4.99 | £164.98 | Month 4. ~10–12% cumulative average. |
| Wegovy 2.4mg | £209.99 | £4.99 | £214.98 | Maintenance. 14.9% average (STEP 1 · NEJM 2021). NICE CV approval April 2026. |
Each pen contains 4 weekly doses. Fixed 2026 prices. No subscription, no minimum term, no cancellation fee. Compare: MedExpress £179.99 starting · Boots £176.97 starting · Voy £167+ starting with subscription required.
Am I Eligible for Weight Loss Injections in Bristol?
- ✓ BMI 30 or above — no qualifying condition needed at Slinic
- ✓ BMI 27–29.9 with at least one qualifying condition: T2D, hypertension, cardiovascular disease, high cholesterol, sleep apnoea, NAFLD, PCOS, or obesity-related osteoarthritis
- ✓ Somali, South Asian, Black African/Caribbean, Chinese, Middle Eastern background — BMI 27.5+ without condition, or BMI 23+ with condition — applied automatically at assessment
- ✓ Age 18 or over
- ✗ Contraindications — personal/family history of MTC or MEN2 · pregnant or breastfeeding · under 18 · active pancreatitis · currently on another GLP-1 agonist
Expected Weight Loss Results — Bristol Patients
Based on SURMOUNT-1 (NEJM 2022) — 2,539 patients, 72 weeks. For a patient starting at 100kg:
| Month | Dose | Average % loss | Actual weight (100kg patient) | What patients typically experience |
|---|---|---|---|---|
| Month 1 | 2.5mg | ~3–4% | ~3–4 kg | Appetite significantly quieter within 1–2 weeks. Constant food thoughts reducing. Scale moving. |
| Month 3 | 7.5mg | ~8–9% | ~8–9 kg | Clothes fitting differently. Energy improving. Others beginning to notice. Motivation typically peaks. |
| Month 6 | 10–12.5mg | ~14–15% | ~14–15 kg | Major physical transformation. Blood pressure, blood sugar, lipids all typically improved. Many patients review other medications with their GP at this stage. |
| Month 12 | 15mg | ~20–21% | ~20–21 kg | Profound health transformation. Quality of life, mood, energy, and mobility significantly improved. |
| Month 18 | 15mg | 22.5% | ~22.5 kg | Full SURMOUNT-1 result. 57% of 15mg patients achieved 20%+ total weight loss. |
What Slinic Includes for Bristol Patients
| Included | Details |
|---|---|
| Full clinical assessment | Every prescription reviewed by Shadeia Younis or registered clinical team. Contraindication screening, drug interactions, ethnic threshold assessment. Never automated. |
| Free starter pack | Needles and sharps bin with every first order. Everything you need to begin on day one. |
| Free monthly clinical check-ins | Weight progress, dose escalation, side effect support, nutritional guidance. Always included in price — never charged separately. |
| Next-day cold-chain delivery | All Bristol and BNSSG postcodes: BS1–BS49 covering Bristol City, North Somerset, and South Gloucestershire. Certified 2–8°C throughout transit. |
| No subscription or minimum term | Order when ready. No automatic billing. No cancellation fee. No lock-in. |
| NHS contract + SCOPE + LegitScript | The highest governance standard in UK online weight loss prescribing. Verify at pharmacyregulation.org |
Side Effects — What Bristol Patients Need to Know
| Side effect | Rate at 15mg | Timing | What to do |
|---|---|---|---|
| Nausea | ~32% | First 2–4 weeks each dose increase | Smaller meals, avoid high-fat food. Antiemetics at your free monthly Slinic check-in if persistent. |
| Diarrhoea | ~23% | First 2–4 weeks | Reduce high-fibre foods temporarily. Increase fluids. Loperamide acutely. Review at check-in if persistent. |
| Constipation | ~17% | Variable | Increase fibre and fluid. Macrogol sachets (Movicol, Laxido) from any Bristol pharmacy — no prescription needed. |
| Vomiting | ~11% | First 2–4 weeks | Contact Slinic urgently if unable to keep fluids down for more than 24 hours. |
| Hair thinning | Common with rapid loss | Months 3–6 | Increase protein. Check ferritin with your Bristol GP. Resolves naturally without stopping medication. |
| Injection site reactions | ~7% | Ongoing | Rotate sites: abdomen, thigh, upper arm. Clean technique. Usually mild and self-resolving. |
Bristol Royal Infirmary — Marlborough Street, BS2 8HW · Southmead Hospital — Westbury-on-Trym, BS10 5NB (North Bristol) · Weston General Hospital — Grange Road, BS23 4TQ (North Somerset)
Severe persistent abdominal pain especially radiating to the back — stop medication immediately, attend A&E. Possible pancreatitis.
Facial swelling or difficulty breathing — call 999 immediately. Possible anaphylaxis.
Unable to keep any fluids down for more than 24 hours — call Slinic or NHS 111.
Call 111 for urgent non-emergency advice outside GP hours.
Verifying Your Bristol Weight Loss Injection Provider
| Check | Why | Slinic status |
|---|---|---|
| GPhC registration — pharmacyregulation.org | Legal requirement. The only way to verify any UK online pharmacy. MHRA seized 20M counterfeit doses worth £45M in 2025. | ✓ GPhC No. 1033729 |
| NHS contract | Highest UK pharmacy governance — same audit standards as NHS pharmacies. | ✓ Yes |
| SCOPE Obesity accreditation | Specialist obesity clinical competency. scopeforpractitioners.com | ✓ Yes |
| LegitScript certification | International online pharmacy verification. legitscript.com | ✓ Yes |
| Named registered prescriber | Every prescription reviewed by GMC, GPhC, or NMC registered prescriber — not automated. | ✓ Shadeia Younis MPharmS GPhC No. 2052119 |
| Authorised UK supply chain | MHRA-licensed medication from Eli Lilly and Novo Nordisk’s UK-authorised supply only. | ✓ Eli Lilly + Novo Nordisk UK authorised |
How to Get Started at Slinic — Bristol Patients
- Complete the free 2-minute eligibility assessment at slinic.co.uk/consultation — free, no obligation, no GP referral needed
- Registered prescriber review same working day — Shadeia Younis or her clinical team review your assessment personally. Ethnic threshold assessment included. Never automated.
- Medication dispatched within 24 hours — cold-chain certified to your Bristol BS postcode
- Free monthly check-in scheduled — all remote, all included in price
- Ask your Bristol GP simultaneously for BNSSG tier 3 referral, cardiovascular Wegovy pathway, or QOF T2D Mounjaro pathway. Start both routes today.
Frequently Asked Questions — Weight Loss Injections Bristol
Where can I get weight loss injections in Bristol?
Two legitimate routes. NHS: ask your Bristol GP for a BNSSG ICB tier 3 weight management referral (BMI 35+ with qualifying conditions, 12–18 month wait) — among the shorter NHS waits in England. From April 2026, also ask about the cardiovascular Wegovy pathway (BMI 27+ with established CVD, no T2D) and QOF T2D Mounjaro pathway (T2D patients). Private: Slinic free 2-minute assessment — medication next-day to your Bristol BS postcode. No GP referral needed. Both routes run simultaneously without affecting each other.
How long is the NHS wait for weight loss injections in Bristol?
BNSSG ICB tier 3 weight management waiting times are approximately 12–18 months from GP referral — among the shorter NHS waits in England (compared to 18–30 months in Liverpool or 18–36 months in parts of London). The April 2026 cardiovascular Wegovy and QOF T2D Mounjaro pathways may be significantly faster for eligible patients. Slinic has no waiting list: 24–48 hours from assessment to delivery to all Bristol BS postcodes.
Are there private weight loss injection clinics in Bristol?
Several private aesthetics and health clinics in Bristol offer weight loss injection services. Before using any local provider, verify their GPhC registration at pharmacyregulation.org — not all local providers are GPhC-registered pharmacies with the governance standards required to prescribe prescription-only medicines. Slinic’s online model (free assessment, registered prescriber review, next-day delivery to your BS postcode) is typically faster and more cost-effective than local private clinics, with free monthly clinical check-ins included in the medication price and NHS-contract level governance.
Why does Bristol have a shorter NHS wait than most cities?
BNSSG ICB covers a population of approximately 1 million — smaller than Greater Manchester (2.8M), West Midlands (2.9M), or London (9M) — and Bristol City’s overall obesity rate of 27% is below the national average of 29%. This lower overall obesity burden, combined with BNSSG ICB’s specific commissioning investment in tier 3 services, means Bristol patients typically wait 12–18 months rather than the 18–36 months common in higher-demand areas. That said, 12–18 months is still a long time without treatment — particularly for patients with progressing T2D, cardiovascular risk, or joint disease.
Can I get weight loss injections in Bristol as a Somali patient?
Yes — and the ethnic BMI adjustments at Slinic are particularly important for Bristol’s Somali community. Research consistently documents elevated T2D and cardiovascular risk factors in Somali communities at lower BMIs than the white European reference population. At Slinic, Somali patients qualify at BMI 27.5+ without a qualifying condition, or BMI 23+ with a qualifying condition (such as T2D or hypertension) — compared to the standard thresholds of BMI 30+ and BMI 27+ respectively. State your ethnic background at your Slinic assessment and the correct thresholds are applied automatically.
Can I switch to Slinic from another Bristol provider?
Yes. Cancel or pause your current subscription, complete Slinic’s free eligibility assessment, and tell your prescriber your current dose and treatment history. You do not need to restart from the lowest dose if already established on a higher dose. Medication delivered to your Bristol address within 24 hours of prescription approval. Many Bristol patients switch to Slinic for the lower fixed prices, free monthly check-ins, and NHS-contract level governance.
Is the BNSSG ICB cardiovascular Wegovy pathway available now?
The NICE April 2026 cardiovascular semaglutide prescribing pathway became available from April 2026. BNSSG ICB GP practices should be implementing this from April 2026 onwards — but adoption rates vary by practice. Ask your Bristol GP specifically: “Has your practice implemented the NICE April 2026 cardiovascular semaglutide prescribing pathway?” If they haven’t yet, private Wegovy at Slinic from £99.99/month is immediately available — and the two routes can run simultaneously.
External Resources and References
Official NHS and Regulatory Resources
- NICE TA1026 — Tirzepatide for managing overweight and obesity (June 2025)
- NICE TA875 — Semaglutide for managing overweight and obesity (March 2023)
- NICE cardiovascular guidance — Semaglutide for CVD risk reduction (April 2026)
- NHS England — QOF 2026/27 T2D Mounjaro pathway
- GPhC Register — Slinic verification (No. 1033729)
- MHRA — Report counterfeit medicines
Published Clinical Trial Evidence
- SURMOUNT-1 — Jastreboff AM et al. Tirzepatide Once Weekly for Obesity. NEJM 2022
- STEP 1 — Wilding JPH et al. Semaglutide for Obesity. NEJM 2021
- SURMOUNT-5 — Garvey WT et al. Tirzepatide vs Semaglutide. NEJM 2025
- SELECT — Lincoff AM et al. Semaglutide and Cardiovascular Outcomes. NEJM 2023
- SURPASS-2 — Frias JP et al. Tirzepatide vs Semaglutide in T2D. NEJM 2021
Community Health and Patient Resources
Related Guides
Start Weight Loss Injections in Bristol Today
Same MHRA-licensed medication as BNSSG ICB · Fixed 2026 prices · No waiting list · Next-day cold-chain delivery to all Bristol BS postcodes · GPhC No. 1033729
✓ NHS-contracted
✓ SCOPE Obesity Accredited
✓ LegitScript Certified
✓ Free monthly check-ins
✓ Free starter pack
✓ No subscription
✓ No minimum term
